Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference27 articles.
1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. E14 Guidance: Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. Geneva, Switzerland: ICH; 2005.
2. Stockbridge N, Zhang J, Garnett C, Malik M. Practice and challenges of thorough QT studies. J Electrocardiol. 2012;45:582–587.
3. Malik M, Garnett C, Zhang J. Thorough QT studies: questions and quandries. Drug Saf. 2010;33(1):1–14.
4. Garnett C, Beasley N, Bhattaram V, et al. Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review. J Clin Pharmacol. 2008;48:13–18.
5. Koch H, Raschka C, Banzer W. Diurnal variation of ECG intervals and R or T amplitudes in healthy male subjects assessed by means of spectral and cosinor analysis. Jpn Heart J. 1999;40(1):45–53.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献